205 related articles for article (PubMed ID: 30466840)
1. Use of Long-Acting Reversible Contraception (LARC) and the Depo-Provera Shot in Adolescents.
Itriyeva K
Curr Probl Pediatr Adolesc Health Care; 2018 Dec; 48(12):321-332. PubMed ID: 30466840
[TBL] [Abstract][Full Text] [Related]
2. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
Polaneczky M; Liblanc M
J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
[TBL] [Abstract][Full Text] [Related]
3. The Latest in Teen Pregnancy Prevention: Long-Acting Reversible Contraception.
McClellan K; Temples H; Miller L
J Pediatr Health Care; 2018; 32(5):e91-e97. PubMed ID: 30180941
[TBL] [Abstract][Full Text] [Related]
4. ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
Obstet Gynecol; 2018 May; 131(5):e130-e139. PubMed ID: 29683910
[TBL] [Abstract][Full Text] [Related]
5. Knowledge and Acceptability of Long-Acting Reversible Contraception Among Adolescent Women Receiving School-Based Primary Care Services.
Hoopes AJ; Ahrens KR; Gilmore K; Cady J; Haaland WL; Amies Oelschlager AM; Prager S
J Prim Care Community Health; 2016 Jul; 7(3):165-70. PubMed ID: 27067583
[TBL] [Abstract][Full Text] [Related]
6. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
Harel Z; Biro FM; Kollar LM; Rauh JL
J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
[TBL] [Abstract][Full Text] [Related]
7. Adolescent satisfaction with postpartum contraception and body weight concerns.
Hellerstedt WL; Story M
J Adolesc Health; 1998 Jun; 22(6):446-52. PubMed ID: 9627814
[TBL] [Abstract][Full Text] [Related]
8. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
Usinger KM; Gola SB; Weis M; Smaldone A
J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
[TBL] [Abstract][Full Text] [Related]
9. Teen pregnancy prevention on a LARC: an update on long-acting reversible contraception for the primary care provider.
Dodson NA; Gray SH; Burke PJ
Curr Opin Pediatr; 2012 Aug; 24(4):439-45. PubMed ID: 22732635
[TBL] [Abstract][Full Text] [Related]
10. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
Paul R; Huysman BC; Maddipati R; Madden T
Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
[TBL] [Abstract][Full Text] [Related]
11. Satisfaction with and intention to continue Depo-Provera versus the Mirena IUD among post-partum adolescents through 12 months of follow-up.
Howard DL; Wayman R; Strickland JL
J Pediatr Adolesc Gynecol; 2013 Dec; 26(6):358-65. PubMed ID: 24238267
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
[TBL] [Abstract][Full Text] [Related]
13. Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.
Morgan IA; Zapata LB; Curtis KM; Whiteman MK
J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):402-408. PubMed ID: 30731216
[TBL] [Abstract][Full Text] [Related]
14. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
15. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J
East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686
[TBL] [Abstract][Full Text] [Related]
16. Long-Acting Reversible Contraception for Adolescents.
Fontenot HB; Fantasia HC
Nurs Womens Health; 2015; 19(3):253-9. PubMed ID: 26058908
[TBL] [Abstract][Full Text] [Related]
17. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
Varney SJ; Guest JF
Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832
[TBL] [Abstract][Full Text] [Related]
18. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
19. Attitudes toward long-acting reversible contraception among young women seeking abortion.
Rose SB; Cooper AJ; Baker NK; Lawton B
J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
[TBL] [Abstract][Full Text] [Related]
20. Long-Acting Reversible Contraception Counseling and Use for Older Adolescents and Nulliparous Women.
Gibbs SE; Rocca CH; Bednarek P; Thompson KMJ; Darney PD; Harper CC
J Adolesc Health; 2016 Dec; 59(6):703-709. PubMed ID: 27665153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
